The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia
Identifieur interne : 002918 ( Istex/Corpus ); précédent : 002917; suivant : 002919The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia
Auteurs : Alison M. Elliott ; Benita Halwiindi ; Richard J. Hayes ; Nkandu Luo ; Alwyn G. Mwinga ; George Tembo ; Lieve Machiels ; Ger Steenbergen ; Joseph O. M. Pobee ; Paul Nunn ; Keith P. W. J. McadamSource :
- Transactions of The Royal Society of Tropical Medicine and Hygiene [ 0035-9203 ] ; 1995-01.
English descriptors
- KwdEn :
Abstract
We have examined the impact of human immunodeficiency virus (HIV) on mortality of patients treated for tuberculosis in a prospective study in Lusaka, Zambia. Patients with sputum smear-positive, miliary, or meningeal tuberculosis were prescribed 2 months' daily streptomycin, thiacetazone, isoniazid, rifampicin, and pyrazinamide followed by 6 months thiacetazone and isoniazid; others, 2 months streptomycin, thiacetazone and isoniazid followed by 10 months thiacetazone and isoniazid. 239 patients (65 HIV-negative and 174 HIV-positive) were followed to 2 years from start of treatment. The crude mortality rate ratio for HIV-positive compared with HIV-negative patients over 2 years was 5.00 (95% confidence interval 2.30–10.86). Median survival for HIV-positive patients from the start of treatment was 22 months. At least 34% of HIV-positive patients for whom cause of death was known died from tuberculosis, three-quarters of these during the first month of treatment. Risk factors for death in HIV-positive patients included multi-site tuberculosis, history of prolonged diarrhoea or fever, oral thrush, splenomegaly, anergy to tuberculin, low weight, anaemia or lymphopenia, and poor compliance with regimens containing rifampicin and pyrazinamide. Tuberculosis, even treated, was a major cause of death in patients with HIV infection.
Url:
DOI: 10.1016/0035-9203(95)90668-1
Links to Exploration step
ISTEX:7DF38C617359C35713F86721C258FBBC7B2BD023Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia</title><author><name sortKey="Elliott, Alison M" sort="Elliott, Alison M" uniqKey="Elliott A" first="Alison M." last="Elliott">Alison M. Elliott</name><affiliation><mods:affiliation>School of Medicine, University of Zambia, Lusaka, Zambia</mods:affiliation></affiliation><affiliation><mods:affiliation>London School of Hygiene and Tropical Medicine, London, UK</mods:affiliation></affiliation><affiliation><mods:affiliation>Address for correspondence: A. M. Elliott, University of Colorado Health Sciences Center, Infectious Disease Division, 4200 East Ninth Avenue, Denver, Colorado 80262, USA.</mods:affiliation></affiliation></author><author><name sortKey="Halwiindi, Benita" sort="Halwiindi, Benita" uniqKey="Halwiindi B" first="Benita" last="Halwiindi">Benita Halwiindi</name><affiliation><mods:affiliation>School of Medicine, University of Zambia, Lusaka, Zambia</mods:affiliation></affiliation></author><author><name sortKey="Hayes, Richard J" sort="Hayes, Richard J" uniqKey="Hayes R" first="Richard J." last="Hayes">Richard J. Hayes</name><affiliation><mods:affiliation>London School of Hygiene and Tropical Medicine, London, UK</mods:affiliation></affiliation></author><author><name sortKey="Luo, Nkandu" sort="Luo, Nkandu" uniqKey="Luo N" first="Nkandu" last="Luo">Nkandu Luo</name><affiliation><mods:affiliation>School of Medicine, University of Zambia, Lusaka, Zambia</mods:affiliation></affiliation></author><author><name sortKey="Mwinga, Alwyn G" sort="Mwinga, Alwyn G" uniqKey="Mwinga A" first="Alwyn G." last="Mwinga">Alwyn G. Mwinga</name><affiliation><mods:affiliation>School of Medicine, University of Zambia, Lusaka, Zambia</mods:affiliation></affiliation><affiliation><mods:affiliation>London School of Hygiene and Tropical Medicine, London, UK</mods:affiliation></affiliation></author><author><name sortKey="Tembo, George" sort="Tembo, George" uniqKey="Tembo G" first="George" last="Tembo">George Tembo</name><affiliation><mods:affiliation>School of Medicine, University of Zambia, Lusaka, Zambia</mods:affiliation></affiliation></author><author><name sortKey="Machiels, Lieve" sort="Machiels, Lieve" uniqKey="Machiels L" first="Lieve" last="Machiels">Lieve Machiels</name><affiliation><mods:affiliation>School of Medicine, University of Zambia, Lusaka, Zambia</mods:affiliation></affiliation></author><author><name sortKey="Steenbergen, Ger" sort="Steenbergen, Ger" uniqKey="Steenbergen G" first="Ger" last="Steenbergen">Ger Steenbergen</name><affiliation><mods:affiliation>The Netherlands Development Corporation, do The Netherlands Embassy, Harare, Zimbabwe</mods:affiliation></affiliation></author><author><name sortKey="Pobee, Joseph O M" sort="Pobee, Joseph O M" uniqKey="Pobee J" first="Joseph O. M." last="Pobee">Joseph O. M. Pobee</name><affiliation><mods:affiliation>School of Medicine, University of Zambia, Lusaka, Zambia</mods:affiliation></affiliation></author><author><name sortKey="Nunn, Paul" sort="Nunn, Paul" uniqKey="Nunn P" first="Paul" last="Nunn">Paul Nunn</name><affiliation><mods:affiliation>London School of Hygiene and Tropical Medicine, London, UK</mods:affiliation></affiliation></author><author><name sortKey="Mcadam, Keith P W J" sort="Mcadam, Keith P W J" uniqKey="Mcadam K" first="Keith P. W. J." last="Mcadam">Keith P. W. J. Mcadam</name><affiliation><mods:affiliation>London School of Hygiene and Tropical Medicine, London, UK</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:7DF38C617359C35713F86721C258FBBC7B2BD023</idno><date when="1995" year="1995">1995</date><idno type="doi">10.1016/0035-9203(95)90668-1</idno><idno type="url">https://api.istex.fr/document/7DF38C617359C35713F86721C258FBBC7B2BD023/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">002918</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002918</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia</title><author><name sortKey="Elliott, Alison M" sort="Elliott, Alison M" uniqKey="Elliott A" first="Alison M." last="Elliott">Alison M. Elliott</name><affiliation><mods:affiliation>School of Medicine, University of Zambia, Lusaka, Zambia</mods:affiliation></affiliation><affiliation><mods:affiliation>London School of Hygiene and Tropical Medicine, London, UK</mods:affiliation></affiliation><affiliation><mods:affiliation>Address for correspondence: A. M. Elliott, University of Colorado Health Sciences Center, Infectious Disease Division, 4200 East Ninth Avenue, Denver, Colorado 80262, USA.</mods:affiliation></affiliation></author><author><name sortKey="Halwiindi, Benita" sort="Halwiindi, Benita" uniqKey="Halwiindi B" first="Benita" last="Halwiindi">Benita Halwiindi</name><affiliation><mods:affiliation>School of Medicine, University of Zambia, Lusaka, Zambia</mods:affiliation></affiliation></author><author><name sortKey="Hayes, Richard J" sort="Hayes, Richard J" uniqKey="Hayes R" first="Richard J." last="Hayes">Richard J. Hayes</name><affiliation><mods:affiliation>London School of Hygiene and Tropical Medicine, London, UK</mods:affiliation></affiliation></author><author><name sortKey="Luo, Nkandu" sort="Luo, Nkandu" uniqKey="Luo N" first="Nkandu" last="Luo">Nkandu Luo</name><affiliation><mods:affiliation>School of Medicine, University of Zambia, Lusaka, Zambia</mods:affiliation></affiliation></author><author><name sortKey="Mwinga, Alwyn G" sort="Mwinga, Alwyn G" uniqKey="Mwinga A" first="Alwyn G." last="Mwinga">Alwyn G. Mwinga</name><affiliation><mods:affiliation>School of Medicine, University of Zambia, Lusaka, Zambia</mods:affiliation></affiliation><affiliation><mods:affiliation>London School of Hygiene and Tropical Medicine, London, UK</mods:affiliation></affiliation></author><author><name sortKey="Tembo, George" sort="Tembo, George" uniqKey="Tembo G" first="George" last="Tembo">George Tembo</name><affiliation><mods:affiliation>School of Medicine, University of Zambia, Lusaka, Zambia</mods:affiliation></affiliation></author><author><name sortKey="Machiels, Lieve" sort="Machiels, Lieve" uniqKey="Machiels L" first="Lieve" last="Machiels">Lieve Machiels</name><affiliation><mods:affiliation>School of Medicine, University of Zambia, Lusaka, Zambia</mods:affiliation></affiliation></author><author><name sortKey="Steenbergen, Ger" sort="Steenbergen, Ger" uniqKey="Steenbergen G" first="Ger" last="Steenbergen">Ger Steenbergen</name><affiliation><mods:affiliation>The Netherlands Development Corporation, do The Netherlands Embassy, Harare, Zimbabwe</mods:affiliation></affiliation></author><author><name sortKey="Pobee, Joseph O M" sort="Pobee, Joseph O M" uniqKey="Pobee J" first="Joseph O. M." last="Pobee">Joseph O. M. Pobee</name><affiliation><mods:affiliation>School of Medicine, University of Zambia, Lusaka, Zambia</mods:affiliation></affiliation></author><author><name sortKey="Nunn, Paul" sort="Nunn, Paul" uniqKey="Nunn P" first="Paul" last="Nunn">Paul Nunn</name><affiliation><mods:affiliation>London School of Hygiene and Tropical Medicine, London, UK</mods:affiliation></affiliation></author><author><name sortKey="Mcadam, Keith P W J" sort="Mcadam, Keith P W J" uniqKey="Mcadam K" first="Keith P. W. J." last="Mcadam">Keith P. W. J. Mcadam</name><affiliation><mods:affiliation>London School of Hygiene and Tropical Medicine, London, UK</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Transactions of The Royal Society of Tropical Medicine and Hygiene</title><title level="j" type="abbrev">Trans R Soc Trop Med Hyg</title><idno type="ISSN">0035-9203</idno><idno type="eISSN">1878-3503</idno><imprint><publisher>Royal Society of Tropical Medicine and Hygiene</publisher><date type="published" when="1995-01">1995-01</date><biblScope unit="volume">89</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="78">78</biblScope><biblScope unit="page" to="82">82</biblScope></imprint><idno type="ISSN">0035-9203</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0035-9203</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>HIV</term><term>Zambia</term><term>tuberculosis</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract">We have examined the impact of human immunodeficiency virus (HIV) on mortality of patients treated for tuberculosis in a prospective study in Lusaka, Zambia. Patients with sputum smear-positive, miliary, or meningeal tuberculosis were prescribed 2 months' daily streptomycin, thiacetazone, isoniazid, rifampicin, and pyrazinamide followed by 6 months thiacetazone and isoniazid; others, 2 months streptomycin, thiacetazone and isoniazid followed by 10 months thiacetazone and isoniazid. 239 patients (65 HIV-negative and 174 HIV-positive) were followed to 2 years from start of treatment. The crude mortality rate ratio for HIV-positive compared with HIV-negative patients over 2 years was 5.00 (95% confidence interval 2.30–10.86). Median survival for HIV-positive patients from the start of treatment was 22 months. At least 34% of HIV-positive patients for whom cause of death was known died from tuberculosis, three-quarters of these during the first month of treatment. Risk factors for death in HIV-positive patients included multi-site tuberculosis, history of prolonged diarrhoea or fever, oral thrush, splenomegaly, anergy to tuberculin, low weight, anaemia or lymphopenia, and poor compliance with regimens containing rifampicin and pyrazinamide. Tuberculosis, even treated, was a major cause of death in patients with HIV infection.</div></front></TEI><istex><corpusName>oup</corpusName><author><json:item><name>Alison M. Elliott</name><affiliations><json:string>School of Medicine, University of Zambia, Lusaka, Zambia</json:string><json:string>London School of Hygiene and Tropical Medicine, London, UK</json:string></affiliations></json:item><json:item><name>Benita Halwiindi</name><affiliations><json:string>School of Medicine, University of Zambia, Lusaka, Zambia</json:string></affiliations></json:item><json:item><name>Richard J. Hayes</name><affiliations><json:string>London School of Hygiene and Tropical Medicine, London, UK</json:string></affiliations></json:item><json:item><name>Nkandu Luo</name><affiliations><json:string>School of Medicine, University of Zambia, Lusaka, Zambia</json:string></affiliations></json:item><json:item><name>Alwyn G. Mwinga</name><affiliations><json:string>School of Medicine, University of Zambia, Lusaka, Zambia</json:string><json:string>London School of Hygiene and Tropical Medicine, London, UK</json:string></affiliations></json:item><json:item><name>George Tembo</name><affiliations><json:string>School of Medicine, University of Zambia, Lusaka, Zambia</json:string></affiliations></json:item><json:item><name>Lieve Machiels</name><affiliations><json:string>School of Medicine, University of Zambia, Lusaka, Zambia</json:string></affiliations></json:item><json:item><name>Ger Steenbergen</name><affiliations><json:string>The Netherlands Development Corporation, do The Netherlands Embassy, Harare, Zimbabwe</json:string></affiliations></json:item><json:item><name>Joseph O.M. Pobee</name><affiliations><json:string>School of Medicine, University of Zambia, Lusaka, Zambia</json:string></affiliations></json:item><json:item><name>Paul Nunn</name><affiliations><json:string>London School of Hygiene and Tropical Medicine, London, UK</json:string></affiliations></json:item><json:item><name>Keith P.W.J. McAdam</name><affiliations><json:string>London School of Hygiene and Tropical Medicine, London, UK</json:string></affiliations></json:item></author><subject><json:item><value>HIV</value></json:item><json:item><value>tuberculosis</value></json:item><json:item><value>Zambia</value></json:item></subject><language><json:string>unknown</json:string></language><originalGenre><json:string>research-article</json:string></originalGenre><abstract>We have examined the impact of human immunodeficiency virus (HIV) on mortality of patients treated for tuberculosis in a prospective study in Lusaka, Zambia. Patients with sputum smear-positive, miliary, or meningeal tuberculosis were prescribed 2 months' daily streptomycin, thiacetazone, isoniazid, rifampicin, and pyrazinamide followed by 6 months thiacetazone and isoniazid; others, 2 months streptomycin, thiacetazone and isoniazid followed by 10 months thiacetazone and isoniazid. 239 patients (65 HIV-negative and 174 HIV-positive) were followed to 2 years from start of treatment. The crude mortality rate ratio for HIV-positive compared with HIV-negative patients over 2 years was 5.00 (95% confidence interval 2.30–10.86). Median survival for HIV-positive patients from the start of treatment was 22 months. At least 34% of HIV-positive patients for whom cause of death was known died from tuberculosis, three-quarters of these during the first month of treatment. Risk factors for death in HIV-positive patients included multi-site tuberculosis, history of prolonged diarrhoea or fever, oral thrush, splenomegaly, anergy to tuberculin, low weight, anaemia or lymphopenia, and poor compliance with regimens containing rifampicin and pyrazinamide. Tuberculosis, even treated, was a major cause of death in patients with HIV infection.</abstract><qualityIndicators><score>8.699</score><pdfVersion>1.4</pdfVersion><pdfPageSize>576 x 792 pts</pdfPageSize><refBibsNative>true</refBibsNative><keywordCount>3</keywordCount><abstractCharCount>1343</abstractCharCount><pdfWordCount>4443</pdfWordCount><pdfCharCount>29222</pdfCharCount><pdfPageCount>5</pdfPageCount><abstractWordCount>188</abstractWordCount></qualityIndicators><title>The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia</title><genre><json:string>research-article</json:string></genre><host><title>Transactions of The Royal Society of Tropical Medicine and Hygiene</title><language><json:string>unknown</json:string></language><issn><json:string>0035-9203</json:string></issn><eissn><json:string>1878-3503</json:string></eissn><publisherId><json:string>trstmh</json:string></publisherId><volume>89</volume><issue>1</issue><pages><first>78</first><last>82</last></pages><genre><json:string>journal</json:string></genre></host><categories><wos><json:string>social science</json:string><json:string>public, environmental & occupational health</json:string><json:string>science</json:string><json:string>tropical medicine</json:string></wos><scienceMetrix><json:string>health sciences</json:string><json:string>clinical medicine</json:string><json:string>tropical medicine</json:string></scienceMetrix><inist><json:string>sciences appliquees, technologies et medecines</json:string><json:string>sciences biologiques et medicales</json:string><json:string>sciences medicales</json:string></inist></categories><publicationDate>1995</publicationDate><copyrightDate>1995</copyrightDate><doi><json:string>10.1016/0035-9203(95)90668-1</json:string></doi><id>7DF38C617359C35713F86721C258FBBC7B2BD023</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/document/7DF38C617359C35713F86721C258FBBC7B2BD023/fulltext/pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/document/7DF38C617359C35713F86721C258FBBC7B2BD023/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/7DF38C617359C35713F86721C258FBBC7B2BD023/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a">The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher scheme="https://publisher-list.data.istex.fr">Royal Society of Tropical Medicine and Hygiene</publisher><availability><licence><p>oup</p></licence></availability><p scheme="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-GTWS0RDP-M"></p><date>1995</date></publicationStmt><notesStmt><note type="research-article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</note><note type="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note><note>Clinical studies and pathology</note><note>∗Address for correspondence: A. M. Elliott, University of Colorado Health Sciences Center, Infectious Disease Division, 4200 East Ninth Avenue, Denver, Colorado 80262, USA.</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a">The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia</title><author xml:id="author-0000" corresp="yes"><persName><forename type="first">Alison M.</forename><surname>Elliott</surname></persName><affiliation>School of Medicine, University of Zambia, Lusaka, Zambia</affiliation><affiliation>London School of Hygiene and Tropical Medicine, London, UK</affiliation><affiliation>Address for correspondence: A. M. Elliott, University of Colorado Health Sciences Center, Infectious Disease Division, 4200 East Ninth Avenue, Denver, Colorado 80262, USA.</affiliation></author><author xml:id="author-0001"><persName><forename type="first">Benita</forename><surname>Halwiindi</surname></persName><affiliation>School of Medicine, University of Zambia, Lusaka, Zambia</affiliation></author><author xml:id="author-0002"><persName><forename type="first">Richard J.</forename><surname>Hayes</surname></persName><affiliation>London School of Hygiene and Tropical Medicine, London, UK</affiliation></author><author xml:id="author-0003"><persName><forename type="first">Nkandu</forename><surname>Luo</surname></persName><affiliation>School of Medicine, University of Zambia, Lusaka, Zambia</affiliation></author><author xml:id="author-0004"><persName><forename type="first">Alwyn G.</forename><surname>Mwinga</surname></persName><affiliation>School of Medicine, University of Zambia, Lusaka, Zambia</affiliation><affiliation>London School of Hygiene and Tropical Medicine, London, UK</affiliation></author><author xml:id="author-0005"><persName><forename type="first">George</forename><surname>Tembo</surname></persName><affiliation>School of Medicine, University of Zambia, Lusaka, Zambia</affiliation></author><author xml:id="author-0006"><persName><forename type="first">Lieve</forename><surname>Machiels</surname></persName><affiliation>School of Medicine, University of Zambia, Lusaka, Zambia</affiliation></author><author xml:id="author-0007"><persName><forename type="first">Ger</forename><surname>Steenbergen</surname></persName><affiliation>The Netherlands Development Corporation, do The Netherlands Embassy, Harare, Zimbabwe</affiliation></author><author xml:id="author-0008"><persName><forename type="first">Joseph O.M.</forename><surname>Pobee</surname></persName><affiliation>School of Medicine, University of Zambia, Lusaka, Zambia</affiliation></author><author xml:id="author-0009"><persName><forename type="first">Paul</forename><surname>Nunn</surname></persName><affiliation>London School of Hygiene and Tropical Medicine, London, UK</affiliation></author><author xml:id="author-0010"><persName><forename type="first">Keith P.W.J.</forename><surname>McAdam</surname></persName><affiliation>London School of Hygiene and Tropical Medicine, London, UK</affiliation></author><idno type="istex">7DF38C617359C35713F86721C258FBBC7B2BD023</idno><idno type="ark">ark:/67375/HXZ-H3XQX4ZF-0</idno><idno type="DOI">10.1016/0035-9203(95)90668-1</idno></analytic><monogr><title level="j">Transactions of The Royal Society of Tropical Medicine and Hygiene</title><title level="j" type="abbrev">Trans R Soc Trop Med Hyg</title><idno type="pISSN">0035-9203</idno><idno type="eISSN">1878-3503</idno><idno type="publisher-id">trstmh</idno><idno type="PublisherID-hwp">trstmh</idno><imprint><publisher>Royal Society of Tropical Medicine and Hygiene</publisher><date type="published" when="1995-01"></date><biblScope unit="volume">89</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="78">78</biblScope><biblScope unit="page" to="82">82</biblScope></imprint></monogr></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>1995</date></creation><abstract><p>We have examined the impact of human immunodeficiency virus (HIV) on mortality of patients treated for tuberculosis in a prospective study in Lusaka, Zambia. Patients with sputum smear-positive, miliary, or meningeal tuberculosis were prescribed 2 months' daily streptomycin, thiacetazone, isoniazid, rifampicin, and pyrazinamide followed by 6 months thiacetazone and isoniazid; others, 2 months streptomycin, thiacetazone and isoniazid followed by 10 months thiacetazone and isoniazid. 239 patients (65 HIV-negative and 174 HIV-positive) were followed to 2 years from start of treatment. The crude mortality rate ratio for HIV-positive compared with HIV-negative patients over 2 years was 5.00 (95% confidence interval 2.30–10.86). Median survival for HIV-positive patients from the start of treatment was 22 months. At least 34% of HIV-positive patients for whom cause of death was known died from tuberculosis, three-quarters of these during the first month of treatment. Risk factors for death in HIV-positive patients included multi-site tuberculosis, history of prolonged diarrhoea or fever, oral thrush, splenomegaly, anergy to tuberculin, low weight, anaemia or lymphopenia, and poor compliance with regimens containing rifampicin and pyrazinamide. Tuberculosis, even treated, was a major cause of death in patients with HIV infection.</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>HIV</term></item><item><term>tuberculosis</term></item><item><term>Zambia</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="1995-01">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/document/7DF38C617359C35713F86721C258FBBC7B2BD023/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="corpus oup, element #text not found" wicri:toSee="no header"><istex:xmlDeclaration>version="1.0"</istex:xmlDeclaration><istex:docType PUBLIC="-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" URI="journalpublishing.dtd" name="istex:docType"></istex:docType><istex:document><article article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="hwp">trstmh</journal-id>
<journal-id journal-id-type="publisher-id">trstmh</journal-id>
<journal-title>Transactions of The Royal Society of Tropical Medicine and Hygiene</journal-title>
<abbrev-journal-title>Trans R Soc Trop Med Hyg</abbrev-journal-title>
<issn pub-type="ppub">0035-9203</issn>
<issn pub-type="epub">1878-3503</issn>
<publisher>
<publisher-name>Royal Society of Tropical Medicine and Hygiene</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1016/0035-9203(95)90668-1</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject></subj-group></article-categories>
<title-group>
<article-title>The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Elliott</surname>
<given-names>Alison M.</given-names></name><xref ref-type="corresp" rid="COR1"><sup>∗</sup></xref><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref><xref ref-type="aff" rid="AFF2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Halwiindi</surname>
<given-names>Benita</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hayes</surname>
<given-names>Richard J.</given-names></name><xref ref-type="aff" rid="AFF2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Luo</surname>
<given-names>Nkandu</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mwinga</surname>
<given-names>Alwyn G.</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref><xref ref-type="aff" rid="AFF2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tembo</surname>
<given-names>George</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Machiels</surname>
<given-names>Lieve</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Steenbergen</surname>
<given-names>Ger</given-names></name><xref ref-type="aff" rid="AFF3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pobee</surname>
<given-names>Joseph O.M.</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nunn</surname>
<given-names>Paul</given-names></name><xref ref-type="aff" rid="AFF2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McAdam</surname>
<given-names>Keith P.W.J.</given-names></name><xref ref-type="aff" rid="AFF2"><sup>2</sup></xref>
</contrib>
<aff id="AFF1">
<label>1</label>School of Medicine, University of Zambia, Lusaka, Zambia</aff>
<aff id="AFF2">
<label>2</label>London School of Hygiene and Tropical Medicine, London, UK</aff>
<aff id="AFF3">
<label>3</label>The Netherlands Development Corporation, do The Netherlands Embassy, Harare, Zimbabwe</aff></contrib-group>
<author-notes>
<fn>
<p>Clinical studies and pathology</p></fn>
<corresp id="COR1">
<label>∗</label>Address for correspondence: A. M. Elliott, University of Colorado Health Sciences Center, Infectious Disease Division, 4200 East Ninth Avenue, Denver, Colorado 80262, USA.</corresp></author-notes>
<pub-date pub-type="ppub">
<month>1</month>
<year>1995</year></pub-date>
<volume>89</volume>
<issue>1</issue>
<fpage>78</fpage>
<lpage>82</lpage>
<history><date date-type="received"><day>17</day>
<month>3</month>
<year>1994</year></date><date date-type="rev-recd"><day>16</day>
<month>5</month>
<year>1994</year></date><date date-type="accepted"><day>17</day>
<month>5</month>
<year>1994</year></date></history>
<permissions><copyright-year>1995</copyright-year></permissions>
<abstract>
<title>Abstract</title>
<p>We have examined the impact of human immunodeficiency virus (HIV) on mortality of patients treated for tuberculosis in a prospective study in Lusaka, Zambia. Patients with sputum smear-positive, miliary, or meningeal tuberculosis were prescribed 2 months' daily streptomycin, thiacetazone, isoniazid, rifampicin, and pyrazinamide followed by 6 months thiacetazone and isoniazid; others, 2 months streptomycin, thiacetazone and isoniazid followed by 10 months thiacetazone and isoniazid. 239 patients (65 HIV-negative and 174 HIV-positive) were followed to 2 years from start of treatment. The crude mortality rate ratio for HIV-positive compared with HIV-negative patients over 2 years was 5.00 (95% confidence interval 2.30–10.86). Median survival for HIV-positive patients from the start of treatment was 22 months. At least 34% of HIV-positive patients for whom cause of death was known died from tuberculosis, three-quarters of these during the first month of treatment. Risk factors for death in HIV-positive patients included multi-site tuberculosis, history of prolonged diarrhoea or fever, oral thrush, splenomegaly, anergy to tuberculin, low weight, anaemia or lymphopenia, and poor compliance with regimens containing rifampicin and pyrazinamide. Tuberculosis, even treated, was a major cause of death in patients with HIV infection.</p></abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>HIV</kwd>
<kwd>tuberculosis</kwd>
<kwd>Zambia</kwd></kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>January-February 1995</meta-value>
</custom-meta>
</custom-meta-wrap></article-meta>
</front>
<back>
<ref-list>
<title>References</title>
<ref id="BIB1">
<label>Abouya et al., 1992</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abouya</surname>
<given-names>Y.L.</given-names></name>
<name>
<surname>Beaumel</surname>
<given-names>A.</given-names></name>
<name>
<surname>Lucas</surname>
<given-names>S.</given-names></name>
<name>
<surname>Dago-Akribi</surname>
<given-names>A.</given-names></name>
<name>
<surname>Coulibaly</surname>
<given-names>G.</given-names></name>
<name>
<surname>N'Dhatz</surname>
<given-names>M.</given-names></name>
<name>
<surname>Konan</surname>
<given-names>J.B.</given-names></name>
<name>
<surname>Yapi</surname>
<given-names>A.</given-names></name>
<name>
<surname>De Cock</surname>
<given-names>K.M.</given-names></name>
</person-group>
<article-title><italic>Pneumocystis carinii</italic> pneumonia. An uncommon cause of death in African patients with acquired immunodeficiency syndrome</article-title>
<source>American Review of Respiratory Diseases</source>
<year>1992</year>
<volume>145</volume>
<fpage>617</fpage>
<lpage>620</lpage>
</nlm-citation>
</ref>
<ref id="BIB2">
<label>Batungwanayo et al., 1992</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Batungwanayo</surname>
<given-names>J.</given-names></name>
<name>
<surname>Taelman</surname>
<given-names>H.</given-names></name>
<name>
<surname>Dhote</surname>
<given-names>R.</given-names></name>
<name>
<surname>Bogaerts</surname>
<given-names>J.</given-names></name>
<name>
<surname>Allen</surname>
<given-names>S.</given-names></name>
<name>
<surname>Van de Perre</surname>
<given-names>P.</given-names></name>
</person-group>
<article-title>Pulmonary tuberculosis in Kigali, Rwanda</article-title>
<source>American Review of Respiratory Diseases</source>
<year>1992</year>
<volume>146</volume>
<fpage>53</fpage>
<lpage>56</lpage>
</nlm-citation>
</ref>
<ref id="BIB3">
<label>Berning et al., 1992</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berning</surname>
<given-names>S.</given-names></name>
<name>
<surname>Huitt</surname>
<given-names>G.</given-names></name>
<name>
<surname>Iseman</surname>
<given-names>M.D.</given-names></name>
<name>
<surname>Peloquin</surname>
<given-names>C.A.</given-names></name>
</person-group>
<article-title>Malabsorption of antituberculous medications by patients with aids</article-title>
<source>New England Journal of Medicine</source>
<year>1992</year>
<volume>327</volume>
<fpage>1817</fpage>
<lpage>1818</lpage>
</nlm-citation>
</ref>
<ref id="BIB4">
<label>Chaisson et al., 1987</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chaisson</surname>
<given-names>R.E.</given-names></name>
<name>
<surname>Schecter</surname>
<given-names>G.F.</given-names></name>
<name>
<surname>Theuer</surname>
<given-names>C.P.</given-names></name>
<name>
<surname>Rutherford</surname>
<given-names>G.W.</given-names></name>
<name>
<surname>Echenberg</surname>
<given-names>D.F.</given-names></name>
<name>
<surname>Hopewell</surname>
<given-names>P.C.</given-names></name>
</person-group>
<article-title>Tuberculosis in patients with acquired immunodeficiency syndrome</article-title>
<source>American Review of Respiratory Diseases</source>
<year>1987</year>
<volume>136</volume>
<fpage>570</fpage>
<lpage>574</lpage>
</nlm-citation>
</ref>
<ref id="BIB5">
<label>Colebunders et al., 1989</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Colebunders</surname>
<given-names>R.L.</given-names></name>
<name>
<surname>Ryder</surname>
<given-names>R.</given-names></name>
<name>
<surname>Nilambi</surname>
<given-names>N.</given-names></name>
<name>
<surname>Dikilu</surname>
<given-names>K.</given-names></name>
<name>
<surname>Willame</surname>
<given-names>J.-C.</given-names></name>
<name>
<surname>Kaboto</surname>
<given-names>M.</given-names></name>
<name>
<surname>Bagala</surname>
<given-names>N.</given-names></name>
<name>
<surname>Jeugmans</surname>
<given-names>J.</given-names></name>
<name>
<surname>Muepu</surname>
<given-names>K.</given-names></name>
<name>
<surname>Francis</surname>
<given-names>H.</given-names></name>
<name>
<surname>Mann</surname>
<given-names>J.</given-names></name>
<name>
<surname>Quinn</surname>
<given-names>T.C.</given-names></name>
<name>
<surname>Piot</surname>
<given-names>P.</given-names></name>
</person-group>
<article-title>HIV infection in patients with tuberculosis in Kinshasa, Zaire</article-title>
<source>American Review of Respiratory Diseases</source>
<year>1989</year>
<volume>139</volume>
<fpage>1082</fpage>
<lpage>1085</lpage>
</nlm-citation>
</ref>
<ref id="BIB6">
<label>De Cock et al., 1992</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Cock</surname>
<given-names>K.M.</given-names></name>
<name>
<surname>Soro</surname>
<given-names>B.</given-names></name>
<name>
<surname>Coulibaly</surname>
<given-names>I.M.</given-names></name>
<name>
<surname>Lucas</surname>
<given-names>S.B.</given-names></name>
</person-group>
<article-title>Tuberculosis and HIV infection in sub-Saharan Africa</article-title>
<source>Journal of the American Medical Association</source>
<year>1992</year>
<volume>268</volume>
<fpage>1581</fpage>
<lpage>1587</lpage>
</nlm-citation>
</ref>
<ref id="BIB7">
<label>Duncan et al., 1991</label>
<nlm-citation citation-type="confproc">
<person-group person-group-type="author">
<name>
<surname>Duncan</surname>
<given-names>L.</given-names></name>
<name>
<surname>Elliott</surname>
<given-names>A.</given-names></name>
<name>
<surname>Ebrahim</surname>
<given-names>H.</given-names></name>
<name>
<surname>Hira</surname>
<given-names>S.</given-names></name>
<name>
<surname>Mumba</surname>
<given-names>G.</given-names></name>
<name>
<surname>Hayes</surname>
<given-names>R.</given-names></name>
<name>
<surname>Pobee</surname>
<given-names>J.</given-names></name>
<name>
<surname>Tembo</surname>
<given-names>G.</given-names></name>
<name>
<surname>McAdam</surname>
<given-names>K.</given-names></name>
</person-group>
<article-title>Tuberculin sensitivity and HIV status among patients attending a sexually transmitted disease clinic in Lusaka, Zambia</article-title>
<source>abstract no. WC3104</source>
<year>1991</year>
<conf-name>VIIth International Conference on aids</conf-name>
<conf-loc>Florence 1991</conf-loc>
</nlm-citation>
</ref>
<ref id="BIB8">
<label>Elliott et al., 1992</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elliott</surname>
<given-names>A.M.</given-names></name>
<name>
<surname>Halwiindi</surname>
<given-names>B.</given-names></name>
<name>
<surname>Bagshawe</surname>
<given-names>A.</given-names></name>
<name>
<surname>Hayes</surname>
<given-names>R.</given-names></name>
<name>
<surname>Luo</surname>
<given-names>N.</given-names></name>
<name>
<surname>Pobee</surname>
<given-names>J.O.M.</given-names></name>
<name>
<surname>McAdam</surname>
<given-names>K.</given-names></name>
</person-group>
<article-title>Use of prednisolone in the treatment of HIV-positive tuberculosis patients</article-title>
<source>Quarterly Journal of Medicine</source>
<year>1992</year>
<volume>85</volume>
<fpage>855</fpage>
<lpage>860</lpage>
</nlm-citation>
</ref>
<ref id="BIB9">
<label>Elliott et al., 1993</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elliott</surname>
<given-names>A.M.</given-names></name>
<name>
<surname>Halwiindi</surname>
<given-names>B.</given-names></name>
<name>
<surname>Hayes</surname>
<given-names>R.J.</given-names></name>
<name>
<surname>Luo</surname>
<given-names>N.</given-names></name>
<name>
<surname>Tembo</surname>
<given-names>G.</given-names></name>
<name>
<surname>Machiels</surname>
<given-names>L.</given-names></name>
<name>
<surname>Bem</surname>
<given-names>C.</given-names></name>
<name>
<surname>Steenbergen</surname>
<given-names>S.</given-names></name>
<name>
<surname>Pobee</surname>
<given-names>J.O.M.</given-names></name>
<name>
<surname>Nunn</surname>
<given-names>P.</given-names></name>
<name>
<surname>McAdam</surname>
<given-names>K.</given-names></name>
</person-group>
<article-title>The impact of human immunodeficiency virus on presentation and diagnosis of tuberculosis in a cohort study in Zambia</article-title>
<source>Journal of Tropical Medicine and Hygiene</source>
<year>1993</year>
<volume>96</volume>
<fpage>1</fpage>
<lpage>11</lpage>
</nlm-citation>
</ref>
<ref id="BIB10">
<label>Engelhard et al., 1984</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Engelhard</surname>
<given-names>D.</given-names></name>
<name>
<surname>Stutman</surname>
<given-names>H.R.</given-names></name>
<name>
<surname>Marks</surname>
<given-names>M.I.</given-names></name>
</person-group>
<article-title>Interaction of ketoconazole with rifampicin and isoniazid</article-title>
<source>New England Journal of Medicine</source>
<year>1984</year>
<volume>311</volume>
<fpage>1681</fpage>
<lpage>1683</lpage>
</nlm-citation>
</ref>
<ref id="BIB11">
<label>Eriki et al., 1991</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eriki</surname>
<given-names>P.P.</given-names></name>
<name>
<surname>Okwera</surname>
<given-names>A.</given-names></name>
<name>
<surname>Aisu</surname>
<given-names>T.</given-names></name>
<name>
<surname>Morrissey</surname>
<given-names>A.B.</given-names></name>
<name>
<surname>Ellner</surname>
<given-names>J.J.</given-names></name>
<name>
<surname>Daniel</surname>
<given-names>T.M.</given-names></name>
</person-group>
<article-title>The influence of human immunodeficiency virus on tuberculosis in Kampala, Uganda</article-title>
<source>American Review of Respiratory Disease</source>
<year>1991</year>
<volume>143</volume>
<fpage>185</fpage>
<lpage>187</lpage>
</nlm-citation>
</ref>
<ref id="BIB12">
<label>Laguna et al., 1992</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laguna</surname>
<given-names>F.</given-names></name>
<name>
<surname>Adrados</surname>
<given-names>M.</given-names></name>
<name>
<surname>Ortega</surname>
<given-names>A.</given-names></name>
<name>
<surname>Gozalez-Lahoz</surname>
<given-names>J.M.</given-names></name>
</person-group>
<article-title>Tuberculous meningitis with acellular cerebrospinal fluid in aids patients</article-title>
<source>AIDS</source>
<year>1992</year>
<volume>6</volume>
<fpage>1165</fpage>
<lpage>1167</lpage>
</nlm-citation>
</ref>
<ref id="BIB13">
<label>Llibre et al., 1992</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Llibre</surname>
<given-names>J.M.</given-names></name>
<name>
<surname>Tor</surname>
<given-names>J.</given-names></name>
<name>
<surname>Manterola</surname>
<given-names>J.M.</given-names></name>
<name>
<surname>Carbonell</surname>
<given-names>C.</given-names></name>
<name>
<surname>Roset</surname>
<given-names>J.</given-names></name>
</person-group>
<article-title>Risk stratification for dissemination of tuberculosis in HIV-infected patients</article-title>
<source>Quarterly Journal of Medicine</source>
<year>1992</year>
<volume>82</volume>
<fpage>149</fpage>
<lpage>157</lpage>
</nlm-citation>
</ref>
<ref id="BIB14">
<label>Mukadi et al., 1993</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mukadi</surname>
<given-names>Y.</given-names></name>
<name>
<surname>Perriens</surname>
<given-names>J.H.</given-names></name>
<name>
<surname>St Louis</surname>
<given-names>M.E.</given-names></name>
<name>
<surname>Brown</surname>
<given-names>C.</given-names></name>
<name>
<surname>Prignot</surname>
<given-names>J.</given-names></name>
<name>
<surname>Willame</surname>
<given-names>J.-C.</given-names></name>
<name>
<surname>Pouthier</surname>
<given-names>F.</given-names></name>
<name>
<surname>Kaboto</surname>
<given-names>M.</given-names></name>
<name>
<surname>Ryder</surname>
<given-names>R.W.</given-names></name>
<name>
<surname>Porteals</surname>
<given-names>F.</given-names></name>
<name>
<surname>Piot</surname>
<given-names>P.</given-names></name>
</person-group>
<article-title>Spectrum of immunodeficienc y in HIV-1-infected patients with pulmonary tuberculosis in Zaire</article-title>
<source>Lancet</source>
<year>1993</year>
<volume>342</volume>
<fpage>143</fpage>
<lpage>146</lpage>
</nlm-citation>
</ref>
<ref id="BIB15">
<label>Murray et al., 1990</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murray</surname>
<given-names>C.J.L.</given-names></name>
<name>
<surname>Styblo</surname>
<given-names>K.</given-names></name>
<name>
<surname>Rouillon</surname>
<given-names>A.</given-names></name>
</person-group>
<article-title>Tuberculosis in developing countries: burden, intervention and cost</article-title>
<source>Bulletin of the International Union against Tuberculosis and Lung Disease</source>
<year>1990</year>
<volume>65</volume>
<fpage>6</fpage>
<lpage>24</lpage>
</nlm-citation>
</ref>
<ref id="BIB16">
<label>Mwinga et al., 1991</label>
<nlm-citation citation-type="confproc">
<person-group person-group-type="author">
<name>
<surname>Mwinga</surname>
<given-names>A.</given-names></name>
<name>
<surname>Elliott</surname>
<given-names>A.</given-names></name>
<name>
<surname>Porter</surname>
<given-names>J.</given-names></name>
<name>
<surname>Halwiindi</surname>
<given-names>B.</given-names></name>
<name>
<surname>Luo</surname>
<given-names>N.</given-names></name>
<name>
<surname>Pobee</surname>
<given-names>J.</given-names></name>
<name>
<surname>McAdam</surname>
<given-names>K.</given-names></name>
</person-group>
<article-title>Prevention of HIV-related tuberculosis in Zambia: a pilot study</article-title>
<year>1991</year>
<conf-name>VIth International Conference on AIDS in Africa</conf-name>
<conf-loc>Dakar, December 1991</conf-loc>
<comment>abstract only</comment>
</nlm-citation>
</ref>
<ref id="BIB17">
<label>Nunn et al., 1991</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nunn</surname>
<given-names>P.</given-names></name>
<name>
<surname>Kibuga</surname>
<given-names>D.</given-names></name>
<name>
<surname>Gathua</surname>
<given-names>S.</given-names></name>
<name>
<surname>Brindle</surname>
<given-names>R.</given-names></name>
<name>
<surname>Imalingat</surname>
<given-names>A.</given-names></name>
<name>
<surname>Wasunna</surname>
<given-names>K.</given-names></name>
<name>
<surname>Lucas</surname>
<given-names>S.</given-names></name>
<name>
<surname>Gilks</surname>
<given-names>C.</given-names></name>
<name>
<surname>Omwega</surname>
<given-names>M.</given-names></name>
<name>
<surname>Were</surname>
<given-names>J.</given-names></name>
<name>
<surname>McAam</surname>
<given-names>K.</given-names></name>
</person-group>
<article-title>Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis</article-title>
<source>Lancet</source>
<year>1991</year>
<volume>337</volume>
<fpage>627</fpage>
<lpage>630</lpage>
</nlm-citation>
</ref>
<ref id="BIB18">
<label>Nunn et al., 1992</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nunn</surname>
<given-names>P.</given-names></name>
<name>
<surname>Brindle</surname>
<given-names>R.</given-names></name>
<name>
<surname>Carpenter</surname>
<given-names>L.</given-names></name>
<name>
<surname>Odhiambo</surname>
<given-names>J.</given-names></name>
<name>
<surname>Wasunna</surname>
<given-names>K.</given-names></name>
<name>
<surname>Newnham</surname>
<given-names>R.</given-names></name>
<name>
<surname>Githui</surname>
<given-names>W.</given-names></name>
<name>
<surname>Gathua</surname>
<given-names>S.</given-names></name>
<name>
<surname>Omwega</surname>
<given-names>M.</given-names></name>
<name>
<surname>McAdam</surname>
<given-names>K.</given-names></name>
</person-group>
<article-title>Cohort study of human immunodeficiency virus infection in tuberculosis patients in Nairobi, Kenya: analysis of early (6-months) mortality</article-title>
<source>American Review of Respiratory Disease</source>
<year>1992</year>
<volume>146</volume>
<fpage>849</fpage>
<lpage>854</lpage>
</nlm-citation>
</ref>
<ref id="BIB19">
<label>Pape et al., 1993</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pape</surname>
<given-names>J.W.</given-names></name>
<name>
<surname>Jean</surname>
<given-names>S.S.</given-names></name>
<name>
<surname>Ho</surname>
<given-names>J.L.</given-names></name>
<name>
<surname>Hafner</surname>
<given-names>A.</given-names></name>
<name>
<surname>Johnson</surname>
<given-names>W.D.</given-names></name>
</person-group>
<article-title>Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection</article-title>
<source>Lancet</source>
<year>1993</year>
<volume>342</volume>
<fpage>268</fpage>
<lpage>272</lpage>
</nlm-citation>
</ref>
<ref id="BIB20">
<label>Perriens et al., 1991</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perriens</surname>
<given-names>P.J.</given-names></name>
<name>
<surname>Colebunders</surname>
<given-names>R.L.</given-names></name>
<name>
<surname>Karahunga</surname>
<given-names>C.</given-names></name>
<name>
<surname>Willame</surname>
<given-names>J.-C.</given-names></name>
<name>
<surname>Jeugmans</surname>
<given-names>J.</given-names></name>
<name>
<surname>Kaboto</surname>
<given-names>M.</given-names></name>
<name>
<surname>Mukadi</surname>
<given-names>Y.</given-names></name>
<name>
<surname>Pauwels</surname>
<given-names>P.</given-names></name>
<name>
<surname>Ryder</surname>
<given-names>R.</given-names></name>
<name>
<surname>Prignot</surname>
<given-names>J.</given-names></name>
<name>
<surname>Piot</surname>
<given-names>P.</given-names></name>
</person-group>
<article-title>Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with ‘standard’ chemotherapy in Kinshasa, Zaire</article-title>
<source>American Review of Respiratory Disease</source>
<year>1991</year>
<volume>144</volume>
<fpage>750</fpage>
<lpage>755</lpage>
</nlm-citation>
</ref>
<ref id="BIB21">
<label>Raviglione et al., 1992</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raviglione</surname>
<given-names>M.C.</given-names></name>
<name>
<surname>Narain</surname>
<given-names>J.P.</given-names></name>
<name>
<surname>Kochi</surname>
<given-names>A.</given-names></name>
</person-group>
<article-title>HIV-associated tuberculosis in developing countries: clinical features, diagnosis and treatment</article-title>
<source>Bulletin of the World Health Organization</source>
<year>1992</year>
<volume>70</volume>
<fpage>515</fpage>
<lpage>526</lpage>
</nlm-citation>
</ref>
<ref id="BIB22">
<label>Small et al., 1991</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Small</surname>
<given-names>P.M.</given-names></name>
<name>
<surname>Schecter</surname>
<given-names>G.F.</given-names></name>
<name>
<surname>Goodman</surname>
<given-names>P.C.</given-names></name>
<name>
<surname>Sande</surname>
<given-names>M.A.</given-names></name>
<name>
<surname>Chaisson</surname>
<given-names>R.E.</given-names></name>
<name>
<surname>Hopewell</surname>
<given-names>P.C.</given-names></name>
</person-group>
<article-title>Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection</article-title>
<source>New England Journal of Medicine</source>
<year>1991</year>
<volume>324</volume>
<fpage>289</fpage>
<lpage>294</lpage>
</nlm-citation>
</ref>
<ref id="BIB23">
<label>Soriano et al., 1988</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soriano</surname>
<given-names>E.</given-names></name>
<name>
<surname>Mallolas</surname>
<given-names>J.</given-names></name>
<name>
<surname>Gatell</surname>
<given-names>J.</given-names></name>
<name>
<surname>Latorre</surname>
<given-names>X.</given-names></name>
<name>
<surname>Miro</surname>
<given-names>J.M.</given-names></name>
<name>
<surname>Pecchiar</surname>
<given-names>M.</given-names></name>
<name>
<surname>Mensa</surname>
<given-names>J.</given-names></name>
<name>
<surname>Trilla</surname>
<given-names>A.</given-names></name>
<name>
<surname>Moreno</surname>
<given-names>A.</given-names></name>
</person-group>
<article-title>Characteristics of tuberculosis in HIV infected patients: a case-control study</article-title>
<source>AIDS</source>
<year>1988</year>
<volume>2</volume>
<fpage>429</fpage>
<lpage>432</lpage>
</nlm-citation>
</ref>
<ref id="BIB24">
<label>Toossi et al., 1992</label>
<nlm-citation citation-type="confproc">
<person-group person-group-type="author">
<name>
<surname>Toossi</surname>
<given-names>Z.</given-names></name>
<name>
<surname>Sierraq-Madero</surname>
<given-names>J.</given-names></name>
<name>
<surname>Rich</surname>
<given-names>E.A.</given-names></name>
</person-group>
<article-title>Increased production of human immunodeficiency virus (HIV) following <italic>in vitro</italic> infection of monocytes from patients with pulmonary tuberculosis</article-title>
<source>abstract no. 13-08</source>
<year>1992</year>
<conf-name>World Congress on Tuberculosis</conf-name>
<conf-loc>Washington, November 1992</conf-loc>
</nlm-citation>
</ref>
</ref-list>
</back>
</article></istex:document></istex:metadataXml><mods version="3.6"><titleInfo><title>The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia</title></titleInfo><titleInfo type="alternative" contentType="CDATA"><title>The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia</title></titleInfo><name type="personal" displayLabel="corresp"><namePart type="given">Alison M.</namePart><namePart type="family">Elliott</namePart><affiliation>School of Medicine, University of Zambia, Lusaka, Zambia</affiliation><affiliation>London School of Hygiene and Tropical Medicine, London, UK</affiliation><affiliation>Address for correspondence: A. M. Elliott, University of Colorado Health Sciences Center, Infectious Disease Division, 4200 East Ninth Avenue, Denver, Colorado 80262, USA.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Benita</namePart><namePart type="family">Halwiindi</namePart><affiliation>School of Medicine, University of Zambia, Lusaka, Zambia</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Richard J.</namePart><namePart type="family">Hayes</namePart><affiliation>London School of Hygiene and Tropical Medicine, London, UK</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Nkandu</namePart><namePart type="family">Luo</namePart><affiliation>School of Medicine, University of Zambia, Lusaka, Zambia</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Alwyn G.</namePart><namePart type="family">Mwinga</namePart><affiliation>School of Medicine, University of Zambia, Lusaka, Zambia</affiliation><affiliation>London School of Hygiene and Tropical Medicine, London, UK</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">George</namePart><namePart type="family">Tembo</namePart><affiliation>School of Medicine, University of Zambia, Lusaka, Zambia</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Lieve</namePart><namePart type="family">Machiels</namePart><affiliation>School of Medicine, University of Zambia, Lusaka, Zambia</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Ger</namePart><namePart type="family">Steenbergen</namePart><affiliation>The Netherlands Development Corporation, do The Netherlands Embassy, Harare, Zimbabwe</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Joseph O.M.</namePart><namePart type="family">Pobee</namePart><affiliation>School of Medicine, University of Zambia, Lusaka, Zambia</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Paul</namePart><namePart type="family">Nunn</namePart><affiliation>London School of Hygiene and Tropical Medicine, London, UK</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Keith P.W.J.</namePart><namePart type="family">McAdam</namePart><affiliation>London School of Hygiene and Tropical Medicine, London, UK</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="research-article" displayLabel="research-article" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</genre><originInfo><publisher>Royal Society of Tropical Medicine and Hygiene</publisher><dateIssued encoding="w3cdtf">1995-01</dateIssued><copyrightDate encoding="w3cdtf">1995</copyrightDate></originInfo><abstract>We have examined the impact of human immunodeficiency virus (HIV) on mortality of patients treated for tuberculosis in a prospective study in Lusaka, Zambia. Patients with sputum smear-positive, miliary, or meningeal tuberculosis were prescribed 2 months' daily streptomycin, thiacetazone, isoniazid, rifampicin, and pyrazinamide followed by 6 months thiacetazone and isoniazid; others, 2 months streptomycin, thiacetazone and isoniazid followed by 10 months thiacetazone and isoniazid. 239 patients (65 HIV-negative and 174 HIV-positive) were followed to 2 years from start of treatment. The crude mortality rate ratio for HIV-positive compared with HIV-negative patients over 2 years was 5.00 (95% confidence interval 2.30–10.86). Median survival for HIV-positive patients from the start of treatment was 22 months. At least 34% of HIV-positive patients for whom cause of death was known died from tuberculosis, three-quarters of these during the first month of treatment. Risk factors for death in HIV-positive patients included multi-site tuberculosis, history of prolonged diarrhoea or fever, oral thrush, splenomegaly, anergy to tuberculin, low weight, anaemia or lymphopenia, and poor compliance with regimens containing rifampicin and pyrazinamide. Tuberculosis, even treated, was a major cause of death in patients with HIV infection.</abstract><note type="footnotes">Clinical studies and pathology</note><note type="author-notes">∗Address for correspondence: A. M. Elliott, University of Colorado Health Sciences Center, Infectious Disease Division, 4200 East Ninth Avenue, Denver, Colorado 80262, USA.</note><subject lang="en"><genre>Keywords</genre><topic>HIV</topic><topic>tuberculosis</topic><topic>Zambia</topic></subject><relatedItem type="host"><titleInfo><title>Transactions of The Royal Society of Tropical Medicine and Hygiene</title></titleInfo><titleInfo type="abbreviated"><title>Trans R Soc Trop Med Hyg</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><identifier type="ISSN">0035-9203</identifier><identifier type="eISSN">1878-3503</identifier><identifier type="PublisherID">trstmh</identifier><identifier type="PublisherID-hwp">trstmh</identifier><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>89</number></detail><detail type="issue"><caption>no.</caption><number>1</number></detail><extent unit="pages"><start>78</start><end>82</end></extent></part></relatedItem><identifier type="istex">7DF38C617359C35713F86721C258FBBC7B2BD023</identifier><identifier type="DOI">10.1016/0035-9203(95)90668-1</identifier><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-GTWS0RDP-M">oup</recordContentSource></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/document/7DF38C617359C35713F86721C258FBBC7B2BD023/metadata/json</uri></json:item></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002918 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 002918 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaSubSaharaV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:7DF38C617359C35713F86721C258FBBC7B2BD023
|texte= The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia
}}
| This area was generated with Dilib version V0.6.32. |  |